Kalamazoo Firm Presents Clinical Trial Results Of Alzheimer's DrugMetabolic Solutions Development Co. LLC announced that Jerry Colca, co-founder and chief scientific officer of MSDC, presented results of a Phase 2a study at the 14th International Conference on Alzheimer's Drug Discovery.
Police Search For Missing Farmington Hills Man With Alzheimer'sPolice are asking for the public's help in finding a missing 79-year-old Farmington Hills man with Alzheimer's disease.
University Of Michigan Professor In $276M Insider Trade Case RetiresA senior University of Michigan medical school faculty member linked to a $276 million insider trading case has retired.
Study Holds Promise For New Alzheimer's TreatmentRadiation is often thought of for just treating cancer, but a new groundbreaking Beaumont study finds in mice that it can treat Alzheimer's.
GVSU Prof Gets NIH Grant To Study Living With Alzheimer'sA Grand Valley State University faculty member received a National Institutes of Health grant to continue researching how patients with Alzheimer's disease use visual cues to navigate their living areas.
Metabolic Solutions To Present On Alzheimer's DrugMetabolic Solutions Development Co. LLC will provide an update on the clinical evaluation of MSDC-0160, a compound being investigated in an ongoing Phase 2a trial in subjects with mild to moderate dementia due to Alzheimer's disease, at the Alzheimer's Drug Discovery Foundation 13th International Conference on Alzheimer's Drug Discovery in Jersey City, N.J. Sept. 10.
Inkster Police Find Missing Alzheimer's Patient An Alzheimer's patient is missing and Inkster police are asking for your help in finding her.
Tetra Gets NIH Award To Develop New Alzheimer's DrugTetra Discovery Partners LLC, a developer of new treatments for major neurological conditions based on PDE4 modulation in the brain, announced it has been awarded a five-year cooperative agreement by the National Institutes of Health. \

Watch & Listen LIVE